Bateman Horne Center Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
1997
NCT00215813
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bateman Horne Center | LUCINDA BATEMAN, MD